Novo Nordisk's weight loss drug Wegovy available in France from Tuesday

FRANCE 24 English

Visit our website: http://www.france24.com  Like us on Facebook: https://www.facebook.com/FRANCE24.English  Follow us on Twitter: https://twitter.com/France24_en

Transcript

00:00A different molecule as diabetes drug Ozempic, but in the same class.

00:05Novo Nordisk's weight loss medication Rigovi goes on sale in France from Tuesday.

00:11Clinical trials for the drug, which has been authorised for use in the European Union since

00:15January 2022, has seen drops of up to 15% of body weight.

00:21Injected daily, the active ingredient in the medication which suppresses hunger is at a

00:25higher dose for Rigovi than Ozempic, and it's a trend that's caught on.

00:31Media mogul Oprah Winfrey, who's battled weight gain over the years, has openly spoken about

00:35its benefits.

00:36Actress and producer Mindy Kaling has been rumoured to have taken the medication to lose

00:40weight, but has remained tight-lipped.

00:43Comedian Amy Schumer admitted to taking Ozempic, but said she quickly stopped due to side effects.

00:49Every drug has a side effect, and we know that obese patients, when they lose a lot

00:54of weight, they lose their muscle mass, and that's really also very serious.

00:59Danish pharmaceutical company Novo Nordisk recently came into the crosshairs of American

01:05lawmakers with prices of its medications 15 times higher in the United States than in

01:11the United Kingdom.

01:12Novo Nordisk has already made billions of dollars in profit off of these products, and

01:17in the coming years will make billions more.

01:20Treat the American people the same way that you treat people all over the world.

01:27Stop ripping us off.

01:30Rigovi's price will not be fixed in France, but according to the company, will cost between

01:359 to 12 euros per day.

01:38According to British medical journal The Lancet, obesity affects one billion people around

01:43the world.

Category

Transcript

Be the first to comment

Recommended